Evidence map›Paper›PMID 33518068›Full record

ArticlePoultry science2021

Research Note: Epidemiological cutoff values and acquired resistance mechanisms of three veterinary antibiotics against Escherichia coli from chicken respiratory tract infections.

Hui-Lin Zhang, Si-Li Wu, Jia-Li Fu, Hong-Xia Jiang, Huan-Zhong Ding

Open access · goldAbstract read
In one paragraph

Article in Poultry science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Resistance Mechanisms of Fluoroquinolone inAntibiotics (Basel, Switzerland) · 2025
    Article
  2. Review
  3. Article
  4. Epidemiological Cut-Off Values and Multidrug Resistance ofAnimals : an open access journal from MDPI · 2022
    Article
  5. Quinolone Resistance ofInternational journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Hui-Lin ZhangGuangdong Key Laboratory for Veterinary Drug Development and Safety Evaluation, South China Agricultural University, 510642 Guangzhou, China.
Si-Li WuNational Risk Assessment Laboratory For Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, 510642 Guangzhou, China.
Jia-Li FuNational Risk Assessment Laboratory For Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, 510642 Guangzhou, China.
Hong-Xia JiangNational Risk Assessment Laboratory For Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, 510642 Guangzhou, China.
Huan-Zhong DingGuangdong Key Laboratory for Veterinary Drug Development and Safety Evaluation, South China Agricultural University, 510642 Guangzhou, China. Electronic address: hzding@scau.edu.cn.
South China Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Florfenicol, apramycin, and danofloxacin are antibiotics approved only for veterinary use and that have good therapeutic effects on chicken respiratory infections caused by Escherichia coli. We established epidemiological cutoff values (ECV) for these antibiotics using 363 E. coli isolates from tracheal samples of chickens in 5 veterinary clinics in Guangdong Province, China. The minimum inhibitory concentrations (MIC) were determined using the agar dilution method as per Clinical and Laboratory Standards Institution guidelines. The ECV were then calculated using the statistical method and verified by normalized resistance interpretation and ECOFFinder software programs. The ECV of florfenicol, apramycin, and danofloxacin against E. coli were 16, 16, and 0.125 μg/mL, respectively. Susceptibility tests indicated that these isolates were resistant to florfenicol (66.7%), apramycin (22.3%), and danofloxacin (92.3%). Strains carrying floR were distributed in the range of MIC ≥32 μg/mL for florfenicol. Apramycin resistance was found in 77 strains (77/363, 21.1%), and isolates that carried aac(3)-IV were all in the range of MIC ≥512 μg/mL. Danofloxacin resistance was found in the range of MIC ≤0.125 μg/mL, but there were no mutations in the quinolone resistance-determining regions and plasmid-mediated quinolone resistance genes qnrA, qnrB, qnrC, qnrD, aac-(6')-Ib-cr, qep, and oqxB. The presence of the qnrS gene was verified in a few of the strains with an MIC of 0.06 μg/mL. The establishment of ECV was significant for monitoring of resistance development and therapy guidance.

Indexed as

ChickensAnimalsAnti-Bacterial AgentsChinaDrug Resistance, BacterialEscherichia coliEscherichia coli InfectionsFluoroquinolonesMicrobial Sensitivity TestsNebramycinPoultry DiseasesRespiratory Tract InfectionsThiamphenicolAnti-Bacterial AgentsapramycindanofloxacinflorfenicolFluoroquinolonesNebramycinThiamphenicolapramycindanofloxacinepidemiological cutoff valueEscherichia coliflorfenicol

Identifiers

PMID33518068
PMCPMC7858166
OpenAlexW3108059352

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.